CMRX Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-26 | 2023 | Michael A. Alrutz, J.D., Ph.D., Senior Vice President, General Counsel and Corporate Secretary | 432,180 | 0 | 42,257 | 128,574 | 11,187 | 793,854 |
| 2021-04-28 | 2020 | Allen Melemed, M.D., M.B.A., Chief Medical Officer | 230,682 | 150,000 | 0 | 127,238 | 999 | 1,443,979 |
| 2020-04-28 | 2019 | Michael A. Sherman, President and Chief Executive Officer | 438,636 | 0 | 0 | 267,300 | 1,165 | 2,644,631 |
| 2020-04-28 | 2019 | Michael T. Andriole, Chief Business and Financial Officer | 292,424 | 0 | 0 | 130,000 | 9,165 | 1,206,601 |
| 2020-04-28 | 2019 | Michael A. Alrutz, J.D., Ph.D., Sr. Vice President, General Counsel | 469,350 | 0 | 233,000 | 139,600 | 10,553 | 1,168,812 |
| 2018-04-26 | 2016 | W. Garrett Nichols, M.D., M.S., Chief Medical Officer | 412,650 | 0 | 368,250 | 105,432 | 9,927 | 1,926,626 |
| 2018-04-26 | 2015 | M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer | 505,700 | 0 | 0 | 164,353 | 1,966 | 5,166,873 |
| 2018-04-26 | 2017 | Timothy W. Trost, C.P.A., Senior Vice President, Chief Financial Officer and Corporate Secretary | 371,669 | 5,854 | 260,855 | 117,076 | 9,787 | 955,965 |
| 2018-04-26 | 2016 | Timothy W. Trost, C.P.A., Senior Vice President, Chief Financial Officer and Corporate Secretary | 359,100 | 0 | 294,600 | 91,750 | 9,927 | 1,785,807 |
| 2018-04-26 | 2015 | Timothy W. Trost, C.P.A., Senior Vice President, Chief Financial Officer and Corporate Secretary | 332,500 | 0 | 0 | 75,644 | 9,916 | 2,004,079 |
| 2018-04-26 | 2017 | W. Garrett Nichols, M.D., M.S., Chief Medical Officer | 427,093 | 13,453 | 312,255 | 134,535 | 9,787 | 1,125,461 |
| 2018-04-26 | 2015 | W. Garrett Nichols, M.D., M.S., Chief Medical Officer | 393,000 | 100,000 | 0 | 89,408 | 9,916 | 1,129,158 |
| 2018-04-26 | 2015 | Linda M. Richardson, Chief Strategy and Commercial Officer | 350,000 | 0 | 0 | 79,625 | 9,915 | 2,025,559 |
| 2018-04-26 | 2016 | Linda M. Richardson, Chief Strategy and Commercial Officer | 367,500 | 0 | 294,600 | 93,896 | 9,927 | 1,796,353 |
| 2018-04-26 | 2017 | Linda M. Richardson, Chief Strategy and Commercial Officer | 380,363 | 0 | 312,255 | 119,814 | 9,787 | 1,050,557 |
| 2018-04-26 | 2017 | M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer | 541,719 | 0 | 760,720 | 243,774 | 9,787 | 2,112,679 |
| 2018-04-26 | 2016 | M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer | 523,400 | 0 | 491,000 | 191,041 | 9,927 | 4,014,873 |
| 2016-04-28 | 2015 | Michael D. Rogers, Ph.D., Chief Development Officer | 332,000 | 0 | 0 | 75,530 | 3,626 | 1,997,224 |
| 2016-04-28 | 2015 | M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer | 505,700 | 0 | 0 | 164,353 | 1,966 | 5,166,873 |
| 2016-04-28 | 2014 | M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer | 419,273 | 0 | 0 | 294,800 | 1,318 | 3,480,756 |
| 2016-04-28 | 2013 | M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer | 340,000 | 0 | 0 | 97,750 | 1,318 | 439,068 |
| 2016-04-28 | 2015 | Timothy W. Trost, C.P.A., Senior Vice President, Chief Financial Officer and Corporate Secretary | 332,500 | 0 | 0 | 75,644 | 9,916 | 2,004,079 |
| 2016-04-28 | 2015 | W. Garrett Nichols, M.D., M.S., Chief Medical Officer | 393,000 | 100,000 | 0 | 89,408 | 9,916 | 1,129,158 |
| 2016-04-28 | 2014 | W. Garrett Nichols, M.D., M.S., Chief Medical Officer | 128,523 | 50,000 | 0 | 45,728 | 439 | 1,644,731 |
| 2016-04-28 | 2015 | Linda M. Richardson, Chief Commercial Officer | 350,000 | 0 | 0 | 79,625 | 9,915 | 2,025,559 |
| 2016-04-28 | 2014 | Linda M. Richardson, Chief Commercial Officer | 333,560 | 0 | 0 | 159,460 | 126,318 | 1,786,536 |
| 2015-04-29 | 2014 | M. Michelle Berrey, M.D., M.P.H. President and Chief Executive Officer | 419,273 | 0 | 0 | 294,800 | 1,318 | 3,480,756 |
| 2015-04-29 | 2013 | M. Michelle Berrey, M.D., M.P.H. President and Chief Executive Officer | 340,000 | 0 | 0 | 97,750 | 1,318 | 439,068 |
| 2015-04-29 | 2014 | Linda M. Richardson | 333,560 | 0 | 0 | 159,460 | 126,318 | 1,786,536 |
| 2015-04-29 | 2014 | W. Garret Nichols, M.D., M.S. | 128,523 | 0 | 0 | 45,728 | 50,439 | 1,644,731 |
| 2015-04-29 | 2014 | Kenneth I. Moch Former President and Chief Executive Officer | 702,751 | 0 | 0 | 0 | 84,290 | 3,502,571 |
| 2015-04-29 | 2013 | Kenneth I. Moch Former President and Chief Executive Officer | 440,274 | 0 | 0 | 226,920 | 1,318 | 668,512 |
| 2014-04-29 | 2013 | Michael Rogers, Ph.D. Chief Development Officer | 228,125 | 0 | 0 | 68,750 | 988 | 817,073 |
| 2014-04-29 | 2012 | Kenneth I. Moch Former President and Chief Executive Officer | 427,450 | 0 | 0 | 85,940 | 1,318 | 797,349 |
| 2014-04-29 | 2013 | Kenneth I. Moch Former President and Chief Executive Officer | 440,274 | 0 | 0 | 226,920 | 1,318 | 668,512 |
| 2014-04-29 | 2012 | M. Michelle Berrey, M.D., M.P.H. President, Chief Executive Officer and Chief Medical Officer | 47,731 | 0 | 0 | 0 | 110 | 546,970 |
| 2014-04-29 | 2013 | M. Michelle Berrey, M.D., M.P.H. President, Chief Executive Officer and Chief Medical Officer | 340,000 | 0 | 0 | 97,750 | 1,318 | 439,068 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
